Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

BUY
$0.36 - $0.49 $4,325 - $5,887
12,015 New
12,015 $4,000
Q1 2021

May 19, 2021

SELL
$4.39 - $9.08 $84,156 - $174,063
-19,170 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$3.86 - $5.07 $73,996 - $97,191
19,170 New
19,170 $83,000
Q3 2020

Dec 11, 2020

SELL
$4.11 - $6.45 $84,850 - $133,160
-20,645 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$5.75 - $11.99 $118,708 - $247,533
20,645 New
20,645 $124,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.